EGFR-homing double-stranded RNA vector for systemic cancer treatment

Details for Australian Patent Application No. 2009332522 (hide)

Owner Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Inventors Levitzki, Alexander; Shir, Alexei

Agent FB Rice

Pub. Number AU-A-2009332522

PCT Pub. Number WO2010/073247

Priority 61/139,698 22.12.08 US

Filing date 22 December 2009

Wipo publication date 1 July 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/117 (2010.01) Mutation or genetic engineering - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

Event Publications

11 August 2011 PCT application entered the National Phase

  PCT publication WO2010/073247 Priority application(s): WO2010/073247

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009332531-Asphalt-mineral compositions containing a cationic organosilicon compound

2009332516-Digital retro-directive communication system and method thereof